A Clinic Trail on Nutrition Support Therapy of Patients With Liver Failure

Tongji Hospital0 sites100 target enrollmentMay 10, 2019

ConditionsNutrition

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Nutrition
Sponsor: Tongji Hospital
Enrollment: 100
Primary Endpoint: Mortality at 30 day
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

This study is a Clinical trial to assess the efficacy of nutrition support therapy of patients with liver failure. Patients were randomized to one of 2 groups to receive different nutrition and energy support treatment.

Detailed Description

Patients with liver failure (defined by APASL) induced by any precipitating factors were randomized to two groups; a treatment group and a control group. Participants in treatment group were provided with a standard hospital diet that provided 25-30 kcal/kg/day . Patients in control group receive diet guide

Registry

clinicaltrials.gov

Start Date

May 10, 2019

End Date

June 1, 2022

Last Updated

6 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Tongji Hospital

Responsible Party

Principal Investigator

Qin Ning

Director and Chair of Department of Infectious Diseases

Tongji Hospital

Eligibility Criteria

Inclusion Criteria

•Male and female patients from 18 to 65 years of age;
•Patient inclusion criteria: jaundice (serum total bilirubin ≥5 mg/dl) and coagulopathy (INR ≥ 1.5 or prothrombin activity ≥ 40 %), accompanied by ascites and/or encephalopathy within 4 weeks.